AstraZeneca falls as fraud investigation reportedly expands in China (update)
An insurance fraud investigation linked to AstraZeneca (AZN) expands in China involving dozens of senior executives. Read more here.
Chinese authorities probing ‘dozens’ of AstraZeneca executives, Yicai reports
Chinese authorities are investigating dozens of senior AstraZeneca (AZN) China executives amid an ongoing insurance fraud case, Yicai Global
AstraZeneca: China's investigation into exec separate from medical insurance probe
AstraZeneca said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top executive in the country, Leon Wang, is separate from a large health insurance fraud case also involving the company.
AstraZeneca Falls Most Since 2020 as China Probe Fears Mount
AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns over a Chinese probe into the UK drugmaker.Most Read from BloombergFrom Housing to Immigration,
AstraZeneca Stock Falls on China Probe Fears
AstraZeneca shares fell 8% in London Tuesday, the biggest drop in four years following a fresh report that a Chinese investigation of the company has widened. AstraZeneca said last week that its China chief,
AstraZeneca falls on reports of Chinese probe
Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of senior executives in the company's China subsidiary have been implicated in an insurance fraud case.
AstraZeneca shares fall on report of potential China probe fallout
AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior executives at its China unit could be implicated in the largest insurance fraud case in the country's pharma sector in years.
AstraZeneca extends losses as Chinese probe widens
AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former executives of the company.
Yicai Global15m
US Food and Agriculture Pavilion Signs USD815 Million of Deals on First Day of Opening at CIIE
(Yicai) Nov. 7 -- The American Food and Agricultural Pavilion penned contracts worth USD815 million on its opening day at the 7th China International Import Expo yesterday, a 65 percent jump from last ...
AstraZeneca's China chief in custody, believes unrelated to insurance probe
AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...
pharmaphorum1d
AZ shares weaken as China investigation rumours swirl
AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest ...
Yicai Global12h
China Sales Decline for Top Car Multinationals as Local EV Brands Thrive
Foreign carmakers are losing ground in the world's biggest auto market. As the Chinese market for combustion engine vehicles shrinks, local automakers such as BYD, Geely Holding Group, and Li Auto ...
BioSpace17h
AstraZeneca’s Stock Price Takes a Hit as China Chief Investigated for Insurance Fraud
BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...
AstraZeneca says does not comment on media reports as shares slump
AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...
Over £14bn wiped off AstraZeneca amid China fears
AstraZeneca suffered a £14bn share price hit on Tuesday after Chinese media reported more details about an investigation into ...
globalconstructionreview9d
Chinese battery maker to close European operations
The decision comes after media reports said it had indefinitely suspended plans to build two battery plants in Germany. The ...